Infectious Diseases

A look at vaccine registries: what they are, and why they are so crucial.

Sharing how vaccinations first began and were implemented can be a useful tool in educating families of their importance.

Ocugen, Inc. has submitted a request to the US Food and Drug Administration for emergency use authorization (EUA) for their COVID-19 vaccine candidate for use in children aged 2-18 years.

Effective vaccines are one of the greatest public health achievements. Dr. Tina Q. Tan shares how the November issue is dedicated to vaccines, from the history to tackling vaccine hesitancy.

Contemporary Pediatrics sat down with editor-in-chief Dr. Tina Q. Tan to discuss the approval of the COVID-19 vaccine for children aged 5 to 11 years and conversations with parents.

Rochelle Walensky, MD endorsed the recommendation from the members of the CDC's Advisory Committee on Immunization Practices to administer Pfizer/BioNTech's COVID-19 vaccine for children aged 5-11 years.

The US Food and Drug Administration (FDA) has amended the emergency use authorization of the Pfizer/BioNTech vaccine to include children aged 5 to 11 years.

The US Food and Drug Administration (FDA) committee voted on whether the emergency use authorization should be extended to children aged 5 to 11 years.

The US Food and Drug Administration (FDA) is meeting to discuss amending the emergency use authorization of the Pfizer/BioNTech vaccine for children aged 5 to 11 years.

Dr. Tan shares her must-reads from the October issue.

Seqirus’s FLUCELVAX® cell-based quadrivalent influenza vaccine has been approved to expand the age indication to children as young as 6 months of age by the US Food and Drug Administration.

Between the subtle differences between viral and bacterial pneumonia and the demands or beliefs of certain parents can make an accurate diagnosis of community-acquired pneumonia (CAP) more difficult.

A look at what the pandemic and its many changes meant for the education of children with disabilities, presented at the virtual 2021 American Academy of Pediatrics National Conference & Exhibition.

At the virtual 2021 American Academy of Pediatrics National Conference & Exhibition, Ibukun Kalu, MD, discussed what is known about the pathophysiology of multisystem inflammatory syndrome in children and implications for related diseases such as Kawasaki syndrome.

The winter season of respiratory diseases is nearly here. Knowing how to manage community-acquired pneumonia is essential.

Initial results from the trial indicate it was well-tolerated and promoted a good immune response.

Long COVID remains a mystery, more than a year after the condition first arose. To find answers, the National Institutes of Health (NIH) has created a research initiative, awarding grants totaling roughly $470 million.

Taxpayers ultimately picking up the tab for those refusing the jab.

The pandemic has increased awareness for many infectious diseases, including croup.

Anthony S. Fauci, MD, Director of the National Institute of Allergy and Infectious Disease, reveals when he believes a COVID-19 vaccine for children aged less than 12 years will be available.

A look at the top COVID-19 nucleic-acid amplification tests and antigen-based assays.

The latest report from the American Academy of Pediatrics (AAP) and the Children's Hospital Association indicates that case of COVID-19 in children are continuing to sharply climb.

The US Food and Drug Administration has issued 501(k) clearance for Visby Medical’s Sexual Health Click Test, a single-use, instrument-free polymerase chain reaction diagnostic test for sexually transmitted infections.

As we begin to emerge from the national lockdown due to the COVID-19 pandemic, many pediatricians may find that the already widespread problem of youth-onset obesity is worse than ever.

The American Academy of Pediatrics (AAP) has issued its recommendations for the upcoming influenza season, including guidance on administering the vaccine to patients with COVID-19.

A research letter offers some of the first data on the long-term outcomes of the first children diagnosed with multisystem inflammatory syndrome in children (MIS-C).

With the delta variant leading to more pediatric infections, awareness of initial symptoms in infants is very important.

A press briefing from the Infectious Diseases Society of America focused on the concerns raised by the delta variant and its potential impact on schools.

To protect children and staff at schools, the Infectious Diseases Society of America (IDSA) has recommended using multiple science-based approaches to prevent spread in schools.

For most of the pandemic, COVID-19 has been mild in children. Has this been true for children with underlying health conditions, in particular cancer?